Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives. (nature.com)

Authors: Raufi AG … Manji GA Journal: Nature Communications Published: 2026-08-21 DOI: https://doi.org/10.1038/s41467-026-76559-4